Notable Launches Flow AI to Enhance Healthcare Workflow Automation
Notable has introduced Flow AI, a conversational assistant designed to streamline workflow automation in healthcare, as announced in a press release.
Applications of AI in healthcare, including medical diagnostics, drug discovery, patient care solutions, and biotechnology research.
Notable has introduced Flow AI, a conversational assistant designed to streamline workflow automation in healthcare, as announced in a press release.
Hahn Labs has launched a new AI-powered solution to streamline healthcare call handling during open enrollment, significantly reducing wait times and costs.
Hoth Therapeutics has expanded its AI initiative by adopting the NVIDIA AI Enterprise platform to enhance drug development and predictive analytics.
Nucs AI has announced the expansion of its leadership team with new appointments to advance AI-driven prostate cancer diagnostics and treatment planning.
DPR Construction's latest report reveals how AI is transforming healthcare construction by improving project delivery and efficiency.
BD and Opentrons have announced a multi-year collaboration to integrate robotic automation into BD's single-cell multiomics instruments, enhancing disease research and drug development.
POMDOCTOR Limited, a leading online medical services platform in China, has announced the pricing of its initial public offering on Nasdaq, aiming to raise approximately $20 million.
TransCelerate BioPharma is pushing forward with its Digital Data Flow initiative to modernize clinical trials through digital protocols, as announced in a recent press release.
InsightRX, a leader in precision dosing AI solutions, has been recognized in the 2025 KLAS Emerging Company Spotlight report with a performance score of 96.1, highlighting its impact on clinical decision support.
Qualtrics has announced a $6.75 billion acquisition of Press Ganey Forsta, aiming to enhance AI-powered experience management in healthcare.
AstraZeneca has entered a $555 million partnership with Algen Biotechnologies to develop gene-editing therapies using AI and CRISPR technology.
Made Scientific and Streamline Bio have successfully validated Streamline Bio's AI-driven robotics platform in a live cell therapy production environment, as announced in a press release. The collaboration aims to integrate the platform into GMP cleanrooms for commercial-scale implementations.
Halia Therapeutics has appointed Paul Jones as Chief Strategy Officer & GM, International Markets to accelerate its GENMOR-AI platform, according to a press release.
Heidi, a Melbourne-based AI startup, has raised $65 million in a Series B funding round led by Point72 Private Investments, boosting its valuation to $465 million.
A Microsoft-led team discovered that AI-generated toxins can bypass DNA security measures, prompting a call for improved biosecurity protocols.
Embleema, in collaboration with GRAVL and Aria Diagnostics, has been awarded a $5 million contract by the Department of Defense to deploy a biosecurity platform for real-time global pathogen detection.
Community Health Network partners with TripleKey to deploy a real-time risk management platform, addressing rising software vulnerabilities in healthcare.
Twin Health's AI Digital Twin technology has been validated by the Validation Institute for its effectiveness in managing diabetes and related conditions, outperforming traditional care methods.
MedHub-AI has received national reimbursement approval in Japan for its AutocathFFR system, enhancing access to AI-driven coronary physiology assessment.
Aisthesis Medical has raised $1.2 million in pre-seed funding to advance its AI-powered platform for predicting sepsis in hospitals.